CoChat

Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

van Lierop, A H, Witteveen, J E, Hamdy, N A T, Papapoulos, S E · 2010 · European Journal of Endocrinology
Cited by 101

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective: In vitro and in vivo studies in animal models have shown that parathyroid hormone (PTH) inhibits the expression of the SOST gene, which encodes sclerostin, an osteocyte-derived negative regulator of bone formation. We tested the hypothesis that chronic PTH excess decreases circulating sclerostin in humans. Design: We studied 25 patients with elevated serum PTH concentrations due to primary hyperparathyroidism (PHPT) and 49 patients cured from PHPT after successful parathyroidectomy (PTx; euparathyroid controls (EuPTH)). Methods: We measured plasma PTH and serum sclerostin levels and the serum markers of bone turnover alkaline phosphatase, P1NP, and β-CTX. Results: As expected by the design of the study, mean plasma PTH was significantly higher (P<0.001) in PHPT patients (15.3 pmol/l; 95% confidence interval (CI): 11.1–19.5) compared with that of EuPTH controls (4.1 pmol/l; 95% CI: 3.6–4.5). PHPT patients had significantly lower serum sclerostin values compared with those in EuPTH subjects (30.5 pg/ml; 95% CI: 26.0–35.1 vs 45.4 pg/ml; 95% CI: 40.5–50.2;P<0.001) and healthy controls (40.0 pg/ml; 95% CI: 37.1–42.9;P=0.01). Plasma PTH concentrations were negatively correlated with serum sclerostin values (r=−0.44;P<0.001). Bone turnover markers were significantly correlated with PTH, but not with sclerostin. Conclusion: Patients with PHPT have significantly lower serum sclerostin values compared with PTx controls with normal PTH concentrations. The negative correlation between PTH and sclerostin suggests that SOST is downregulated by PTH in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-10-0699

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 101

Metadata

Authors
van Lierop, A. H., Witteveen, J. E., Hamdy, N. A. T., & Papapoulos, S. E.
Venue
European Journal of Endocrinology
Published
2010-11
Volume
163
Issue
5
Pages
833-837
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2138610691
Cited by
101
References
6
FWCI
8.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls. https://app.cochat.ai/papers/10.1530/eje-10-0699
The paper
van Lierop, A. H., Witteveen, J. E., Hamdy, N. A. T., & Papapoulos, S. E. (2010). Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls. European Journal of Endocrinology. https://doi.org/10.1530/eje-10-0699

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.